Urokinase – Green Cross Inj. 60,OOOIU
Taiwan Green Cross Co., Ltd
Quick Info
Acute coronary artery obstruction, clean venous catheter, acute pulmonary obstruction. Peripheral artery and venous obstruction.
Acute coronary artery obstruction, clean venous catheter, acute pulmonary obstruction. Peripheral artery and venous obstruction.
60,000 [U x 10 vial
Generally, 10 ml of physiological saline or glucose solution is used to dissolve the contents of the bottle and then intravenously inject it; it can also be diluted in an appropriate amount of physiological saline or glucose solution and dissolved for intravenous drip injection. [Thrombotic obstructive diseases] ● Peripheral artery and venous embolism: Use 60,000~240,000 I,U. on the first day, then gradually reduce the dosage and continue to use for about 7 days.
Medicine
Etoposide Injection
Mainly used to treat small cell lung cancer, malignant lymphoma, malignant germ cell tumor, leukemia, neuroblastoma, rhabdomyosarcoma, ovarian cancer, non-small...
Sintilimab Injection
Classical Hodgkin's lymphoma, Non-squamous non-small cell lung cancer, Squamous non-small cell lung cancer, Hepatocellular carcinoma, Esophageal squamous cell carcinoma, Gastric...
Apatinib Mesylate Tablets
This product is suitable for patients with advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed or relapsed after...
Anlotinib Hydrochloride Capsules
Anlotinib is a new small molecule tyrosine kinase inhibitor of multi-targets, which acts effectively on targets such as VEGFR, PDGFR,...
Related News
China’s innovative drugs gain momentum in global expansion efforts
Virtual mental health care visits: Making them work for youChinese-made new drugs big hit overseasVirtual mental health care visits: Making them work for you
Accelerating Chinese Innovative Drugs Going Global: International New Drug R&D Regulation Forum Successfully Held